Humacyte
HUMA
HUMA
78 hedge funds and large institutions have $43.1M invested in Humacyte in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
42% less capital invested
Capital invested by funds: $74M → $43.1M (-$30.9M)
59% less call options, than puts
Call options by funds: $332K | Put options by funds: $806K
Holders
78
Holding in Top 10
2
Calls
$332K
Puts
$806K
Top Buyers
1 | +$3.53M | |
2 | +$2.63M | |
3 | +$955K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$809K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$572K |
Top Sellers
1 | -$745K | |
2 | -$501K | |
3 | -$420K | |
4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$352K |
5 |
![]()
Simplex Trading
Chicago,
Illinois
|
-$235K |